News

Under the leadership of the University Medical Center Göttingen (UMG), researchers in Göttingen, together with audiologists and artists from the fields of film and music, have translated the sound experience with an optogenetic cochlear implant into images and sound. The music video artistically conveys the restoration of ‘hearing with light’,

Frankfurter Allgemeine Sonntagszeitung reports on hearing research in Göttingen: A new dimension of hearing for those who are deaf or extremely hard of hearing. A large research network in Göttingen around MBExC member Tobias Moser is developing a high-tech hearing aid that uses light and genetic engineering to enable hearing.

Scientists from the ‘Molecular Pharmacology’ working group at the Institute of Pharmacology and Toxicology at the University Medical Center Göttingen (UMG) have been awarded this year’s Oskar Lapp Research Award. Dr. Funsho Fakuade, postdoctoral researcher, and medical students Dominik Hubricht and Vanessa Möller were presented with the award at the

Within the framework of the Research Training Group (RTG) 2824 “Heart & Brain diseases: integrative research across organs”, MBExC member Tobias Brügmann and scientists from the RTG2824 had the exciting opportunity to show students of the Otto-Hahn-Gymnasium (OHG) in Göttingen the fascinating connections between the heart and brain. The session

Founded in January 2025, Ovo Labs is a biotech company that has emerged from the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen (Germany). The company develops novel therapeutics to improve the quality of human eggs. The active compounds are designed to help women remain fertile for longer and

110 scientists clearly affirm their commitment to animal research: “We conduct animal experiments!”   On the occasion of the World Day for Laboratory Animals on 24 April 2025, 110 leading scientists from Germany (including MBExC members) are publicly affirming their commitment to animal research. Under the joint statement “We conduct

With the signing of an equity agreement on April 2, 2025, biotech pioneers Repairon GmbH and life science investor Bioventure Management GmbH, both based in Göttingen, have entered into a strategic partnership with the potential to fundamentally change the treatment of heart failure worldwide. Bioventure is investing in Repairon –

Congratulations to MBExC member Nadja Simeth-Crespi on her appointment as W2 Professor of Molecular Labeling Chemistry at the University of Göttingen!   Prof. Simeth-Crespi and her team’s research intersects the boundaries of bioorganic and photochemistry, with a focus on the design of smart drugs, biochemical probes and labels, as well

Göttingen research team constructs network of self-learning infomorphic neurons   Novel artificial neurons learn independently and are more strongly modeled on their biological counterparts. A team of researchers from the Göttingen Campus Institute for Dynamics of Biological Networks (CIDBN) at the University of Göttingen and the Max Planck Institute for

MBExC member Dr. Thomas Frank has received €360,000 in project funding over three years from the Schram Foundation. His project “Cellular mechanisms and brain-wide circuits of chemosensory valence coding” uses zebrafish as a model organism to investigate how the brain processes sensory information, such as odors, across different levels of